2021 共识报告:2型糖尿病缓解的定义和解释

2021-08-30 美国糖尿病学会 Diabet Med

在一些糖尿病患者中,血糖水平可自发或在药物干预后改善至正常水平。甚至在某些情况下停止降糖药物治疗后,血糖水平和持续改善。本文主要针对这一过程的术语和定义进行确认。

中文标题:

2021 共识报告:2型糖尿病缓解的定义和解释

英文标题:

Consensus report: Definition and interpretation of remission in type 2 diabetes

发布机构:

美国糖尿病学会

发布日期:

2021-08-30

简要介绍:

在一些糖尿病患者中,血糖水平可自发或在药物干预后改善至正常水平。甚至在某些情况下停止降糖药物治疗后,血糖水平和持续改善。本文主要针对这一过程的术语和定义进行确认。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 共识报告:2型糖尿病缓解的定义和解释.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0763e1c002221995, title=2021 共识报告:2型糖尿病缓解的定义和解释, enTitle=Consensus report: Definition and interpretation of remission in type 2 diabetes, guiderFrom=Diabet Med, authorId=0, author=, summary=在一些糖尿病患者中,血糖水平可自发或在药物干预后改善至正常水平。甚至在某些情况下停止降糖药物治疗后,血糖水平和持续改善。本文主要针对这一过程的术语和定义进行确认。, cover=https://img.medsci.cn/20211021/1634792858837_1608702.png, journalId=0, articlesId=null, associationId=54, associationName=美国糖尿病学会, associationIntro=美国糖尿病协会县美国重要的非赢利性卫生姐织,旨在提供有关糖尿病的研究进展和信息,促进糖尿病的科研、教育、诊疗等,关注一切与糖尿病有关的事务。协会成立千 1940年,以预防和治疗糖尿病,改善所有糖尿病患者生活质量为目标。一年一度的全球糖尿病领域最大规模的盛会&mdash;&mdash;美国糖尿病协会(ADA)年会于每年的6月如期而至,每年将有来自世界各地的13000名研究者、医生及其他专业人士莅临,共同分享糖尿病领域前沿研究、治疗建议以及治疗新趋势,聚焦糖尿病领域基础研究与临床实践的最新进展,公布最新临床试验结果,关注如何将研究成果应用于临床实践。, copyright=0, guiderPublishedTime=Mon Aug 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">在一些糖尿病患者中,血糖水平可自发或在药物干预后改善至正常水平。甚至在某些情况下停止降糖药物治疗后,血糖水平和持续改善。本文主要针对这一过程的术语和定义进行确认。</span></p>, tagList=[TagDto(tagId=116279, tagName=2型糖尿病缓解)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2052, guiderKeyword=2型糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=62806, appHits=252, showAppHits=0, pcHits=570, showPcHits=62551, likes=0, shares=23, comments=16, approvalStatus=1, publishedTime=Thu Oct 21 13:23:23 CST 2021, publishedTimeString=2021-08-30, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Oct 21 13:10:56 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 05:35:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 共识报告:2型糖尿病缓解的定义和解释.pdf)])
2021 共识报告:2型糖尿病缓解的定义和解释.pdf
下载请点击:
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200654, encodeId=c3f512006545f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Tue Mar 08 20:16:40 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194658, encodeId=c63a119465845, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:52 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194657, encodeId=a551119465e99, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:47 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080965, encodeId=4e791080965a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Fri Dec 17 00:50:04 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080780, encodeId=e80d1080e8022, content=非常好的学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:34:16 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2022-03-08 Svana

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200654, encodeId=c3f512006545f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Tue Mar 08 20:16:40 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194658, encodeId=c63a119465845, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:52 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194657, encodeId=a551119465e99, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:47 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080965, encodeId=4e791080965a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Fri Dec 17 00:50:04 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080780, encodeId=e80d1080e8022, content=非常好的学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:34:16 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2022-02-18 1351fc2f66m

    看看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200654, encodeId=c3f512006545f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Tue Mar 08 20:16:40 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194658, encodeId=c63a119465845, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:52 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194657, encodeId=a551119465e99, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:47 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080965, encodeId=4e791080965a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Fri Dec 17 00:50:04 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080780, encodeId=e80d1080e8022, content=非常好的学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:34:16 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2022-02-18 1351fc2f66m

    看看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1200654, encodeId=c3f512006545f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Tue Mar 08 20:16:40 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194658, encodeId=c63a119465845, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:52 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194657, encodeId=a551119465e99, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:47 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080965, encodeId=4e791080965a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Fri Dec 17 00:50:04 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080780, encodeId=e80d1080e8022, content=非常好的学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:34:16 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-17 6888

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1200654, encodeId=c3f512006545f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Tue Mar 08 20:16:40 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194658, encodeId=c63a119465845, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:52 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194657, encodeId=a551119465e99, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2128345, createdName=1351fc2f66m, createdTime=Fri Feb 18 00:47:47 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080965, encodeId=4e791080965a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Fri Dec 17 00:50:04 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080780, encodeId=e80d1080e8022, content=非常好的学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:34:16 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-16 ms3000001530930540

    非常好的学习资料

    0

拓展阅读

2014 ADS立场声明:2型糖尿病血糖管理法则

澳大利亚糖尿病协会(ADS,Australian Diabetes Society) · 2014-12-11

2015 AHA/ADA科学声明:成人2型糖尿病患者心血管疾病的预防(更新版)

美国糖尿病学会(ADA,American Diabetes Association) · 2015-08-05

2015 ADA/AADE/AND联合声明:2型糖尿病的自我管理教育和支持

美国糖尿病学会(ADA,American Diabetes Association) · 2015-06-05

2013 中国2型糖尿病防治指南(2013年版)

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2014-08-16